2%) would consider it in all patients. Specific risk factors associated with diabetes where aspirin would be considered favourably included the following: (a) hypertension – 44/117 (37.6%) in favour; (b) microalbuminuria – 36/115 (31.3%) with doctors 26/60 (43.3%) vs nurses 10/55 (18.2%) (c) smoking history – 33/116 (28.4%) with doctors 22/60 (36.7%)

vs nurses 11/56 (19.6%) (d) strong family history of coronary disease – 68/118 (57.6%) (e) high risk this website of coronary disease – 71/119 (59.7%) and (f) hyperlipidaemia – 42/116 (36.2%). This survey confirmed that the controversy in current aspirin guidance was reflected in a varied response regarding views about aspirin use in patients with diabetes and primary prevention of vascular disease. Further clarification/guidance Selleckchem C59 wnt on the optimum prescription of aspirin in diabetes is required. Copyright © 2012 John Wiley & Sons. “
“Pregnancies in women with diabetes are associated with increased perinatal morbidity and mortality, even when the baby is structurally normal. The pathophysiology

of this is poorly understood and likely to be multifactorial. While fetal compromise in women whose diabetes is complicated by vasculopathy, pre-eclampsia or fetal growth restriction is likely due to placental vascular disease, it is difficult to explain the fetal compromise that occurs with accelerated or normal growth. The goal of surveillance is to identify fetuses at risk, in order to intervene in a timely and appropriate fashion, to reduce perinatal morbidity and mortality. None of the currently available surveillance techniques has been proven to predict the fetuses at risk or prevent poor outcome in the setting of

a diabetic pregnancy. This chapter summarises the currently available tools for fetal surveillance and the potential for their use in diabetic pregnancies. It also provides a practical and pragmatic approach to fetal surveillance in these pregnancies. “
“Cystic fibrosis related diabetes is the most common co-morbidity in cystic fibrosis. Insulin deficiency is the key factor in the development of cystic fibrosis related diabetes, which is associated with from worse pulmonary and nutritional morbidity and increased mortality. The oral glucose tolerance test remains standard for screening, but continuous glucose monitoring systems are increasingly used to help with screening and management. Insulin is the only treatment with evidence of benefit. The timing of insulin treatment, and the level of glycaemia for which to aim, are areas which need further research. Treatment is aimed at both optimising nutrition and lung function and reducing the risk of microvascular complications. Copyright © 2010 John Wiley & Sons. “
“As the population ages and the prevalence of diabetes increases, more and more older people will suffer from diabetic complications, including renal disease.